[1] [1] ANG M, FLANAGAN J L, WONG C W, et al. Review: myopia control strategies recommendations from the 2018 WHO/IAPB/BHVI meeting on myopia［J］. British Journal of Ophthalmology, 2020, 104(11): 1482-1487.

[2] [2] MODJTAHEDI B S, ABBOTT R L, FONG D S, et al. Reducing the global burden of myopia by delaying the onset of myopia and reducing myopic progression in children: the academys task force on myopia［J］. Ophthalmology, 2021, 128(6): 816-826.

[3] [3] TIDEMAN J W, SNABEL M C, TEDJA M S, et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia［J］. JAMA Ophthalmol, 2016, 134: 1355-1363.

[4] [4] BANASHEFSKI B, RHEE M K, LEMA G M C. High myopia prevalence across racial groups in the United States: a systematic scoping review［J］. Journal of Clinical Medicine, 2023, 12(8): 3045.

[5] [5] MUHIDDIN H S, MAYASARI A R, UMAR B T, et al. Choroidal thickness in correlation with axial length and myopia degree［J］. Vision (Basel), 2022, 6(1): 16.

[6] [6] HOLDEN B A, FRICKE T R, WILSON D A, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050［J］. Ophthalmology, 2016, 123: 1036-1042.

[7] [7] XIANG F, HE M, ZENG Y, et al. Increases in the prevalence of reduced visual acuity and myopia in Chinese children in Guangzhou over the past 20 years［J］. Eye (Lond), 2013, 27(12): 1353-1358.

[8] [8] DING B Y, SHIH Y F, LIN L L K, et al. Myopia among schoolchildren in East Asia and Singapore［J］. Survey of Ophthalmology, 2017, 62(5): 677-697.

[9] [9] SPILLMANN L. Stopping the rise of myopia in Asia［J］. Graefe’s Archive for Clinical and Experimental Ophthalmology, 2020, 258(5): 943-959.

[10] [10] GRZYBOWSKI A, KANCLERZ P, TSUBOTA K, et al. A review on the epidemiology of myopia in school children worldwide［J］. BMC Ophthalmol, 2020, 20(1): 27.

[11] [11] JOST B J, MARCUS A, PAULINE C, et al. IMI prevention of myopia and its progression［J］. Invest Ophthalmology & Visual Science, 2021, 62(5): 6.

[12] [12] ALRAHILI N H R, JADIDY E S, ALAHMADI B S H, et al. Prevalence of uncorrected refractive errors among children aged 3~10 years in western Saudi Arabia［J］. Saudi Medical Journal, 2017, 38(8): 804-810.

[13] [13] CARTER M J, LANSINGH V C, SCHACHT G, et al. Visual acuity and refraction by age for children of three different ethnic groups in Paraguay［J］. Arquivos Brasileiros De Oftalmologia, 2013, 76(2): 94-97.

[14] [14] MATAMOROS E, INGRAND P, PELEN F, et al. Prevalence of myopia in France: a cross-sectional analysis［J］. Medicine (Baltimore), 2015, 94(45): e1976.

[15] [15] LAN F D, JAMES L, CHRISTINE F, et al. Novel myopia genes and pathways identified from syndromic forms of myopia［J］. Investigative Ophthalmology & Visual Science, 2018, 59(1): 338-348.

[16] [16] WOJCIECHOWSKI R, CHENG C Y. Involvement of multiple molecular pathways in the genetics of ocular refraction and myopia ［J］. Retina, 2018, 38(1): 91-101.

[17] [17] YUAN T, ZOU H. Effects of air pollution on myopia: an update on clinical evidence and biological mechanisms［J］. Environmental Science and Pollution Research, 2022, 29(47): 70674-70685.

[18] [18] YANG B Y, GUO Y, ZOU Z, et al. Exposure to ambient air pollution and visual impairment in children: a nationwide cross-sectional study in China［J］. Journal of Hazardous Materials, 2021, 407: 124750.

[19] [19] ROSE K A, MORGAN I G, IP J, et al. Outdoor activity reduces the prevalence of myopia in children［J］. Ophthalmology, 2008, 115(8): 1279-1285.

[20] [20] MCBRIEN N A, GENTLE A. Role of the sclera in the development and pathological complications of myopia［J］. Progress In Retinal and Eye Research, 2003, 22(3): 307-338.

[21] [21] XIONG S, SANKARIDURG P, NADUVILATH T, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review［J］. Acta Ophthalmologica, 2017, 95(6): 551-566.

[22] [22] ALTHNAYAN Y I, ALMOTAIRI N M, ALHARBI M M, et al. Myopia progression among school-aged children in the COVID-19 distance-learning era［J］. Clinical Ophthalmology, 2023, 17: 283-290.

[23] [23] CHEN Jing. Progression in research of the pathogenesis of myopia ［J］. Chinese Journal of Experimental Ophthalmology, 2012, 30(4): 376-379.

[24] [24] QU D, ZHOU Y. Post-Ortho-K corneal epithelium changes in myopic eyes［J］. Disease Markers, 2022, 2022(2): 3361172.

[25] [25] YAM J C, JIANG Y, TANG S M, et al. Low-concentration atropine for myopia progression (lamp) study: a randomized, doubleblinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control［J］. Ophthalmology, 2019, 126(1): 113-124.

[26] [26] HU P, TAO L. Comparison of the clinical effects between digital keratoplasty and traditional orthokeratology lenses for correcting juvenile myopia［J］. Technology Health Care, 2023: 1-9.

[27] [27] ORTEGA-USOBIAGA J, ROCHA-DE-LOSSADA C, LLOVETRAUSELL A, et al. Update on contraindications in laser corneal refractive surgery［J］. Archivos de la Sociedad Espanola de Oftalmología (English Edition), 2023, 98(2): 105-111.

[28] [28] ZHANG Duoxing, WEI Shifei, WANG Ningli. Mechanism and clinical effects of atropine on myopia progression［J］. Chinese Journal of Experimental Ophthalmology, 2022, 40(6): 594-598.

[29] [29] ZHENG N N, TAN K W. The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia: a meta-analysis［J］. Ophthalmic and Physiological Optics, 2022, 42(6): 1214-1226.

[30] [30] CHEN Z, ZHOU J, XUE F, et al. Two-year add-on effect of using low concentration atropine in poor responders of orthokeratology in myopic children［J］. British Journal of Ophthalmology, 2022, 106(8): 1069-1072.

[31] [31] ZHANG P, ZHU H. Light signaling and myopia development: a review［J］. Ophthalmology and Therapy, 2022, 11(3): 939-957.

[32] [32] YANG W, LIN F, LI M, et al. Immediate effect in retina and choroid after 650 nm low-level red light therapy in children［J］. Ophthalmic Research, 2022, 66 (1): 312-318.

[33] [33] LIU G, LI B, RONG H, et al. Axial length shortening and choroid thickening in myopic adults treated with repeated low-level red light［J］. Journal of Clinical Medicine, 2022, 11(24): 7498.

[34] [34] XIONG F, MAO T, LIAO H, et al. Orthokeratology and low-intensity laser therapy for slowing the progression of myopia in children ［J］. Biomed Research International, 2021, 2021: 8915867.

[35] [35] ZHOU L, XING C, QIANG W, et al. Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort［J］. Ophthalmic and Physiological Optics, 2022, 42(2): 335-344.

[36] [36] JIANG Y, ZHU Z, TAN X, et al. Effect of repeated low-level redlight therapy for myopia control in children: a multicenter randomized controlled trial［J］. Ophthalmology, 2022, 129(5): 509-519.

[37] [37] XIONG R, ZHU Z, JIANG Y, et al. Sustained and rebound effect of repeated low-level red-light therapy on myopia control: a 2-year post-trial follow-up study［J］. Clinical and Experimental Ophthalmology, 2022, 50(9): 1013-1024.

[38] [38] DONG J, ZHU Z, XU H, et al. Myopia control effect of repeated low-level red-light therapy in Chinese children: a randomized, double-blind, controlled clinical trial［J］. Ophthalmology, 2023, 130(2): 198-204.

[39] [39] TIAN L, CAO K, MA D L, et al. Investigation of the efficacy and safety of 650 nm low-level red light for myopia control in children: a randomized controlled trial［J］. Seminars in Ophthalmology, 2022, 11(6): 2259-2270.

[40] [40] CHEN Y, XIONG R, CHEN X, et al. Efficacy comparison of repeated low-level red light and low-dose atropine for myopia control: a randomized controlled trial［J］. Translational Vision Science & Technology, 2022, 11(10): 33.

[41] [41] XIONG R, ZHU Z, JIANG Y, et al. Longitudinal changes and predictive value of choroidal thickness for myopia control after repeated low-level red-light therapy［J］. Ophthalmology, 2023, 130(3): 286-296.

[42] [42] WANG W, JIANG Y, ZHU Z, et al. Axial shortening in myopic children after repeated low-level red-light therapy: post hoc analysis of a randomized trial［J］. Ophthalmology and Therapy, 2023, 12(2): 1223-1237.

[43] [43] HE X, WANG J, ZHU Z, et al. Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial［J］. JAMA Network Open, 2023, 6(4): e239612.

[44] [44] LIN Z H, TAO Z Y, KANG Z F, et al. A study on the effectiveness of a 650-nm red-light feeding instrument in the control and slow the progression of myopia［J］. Ophthalmic Research, 2023, 66(1): 641-648.

[45] [45] TIAN L, CAO K, MA D L, et al. Six-month repeated irradiation of 650 nm low-level red light reduces the risk of myopia in children: a randomized controlled trial [J]. International Ophthalmology, 2023, 43(10): 3549-3558.

[46] [46] ZHANG C X, LOU Y, CHI J, et al. Considerations for the use of photobiomodulation in the treatment of retinal diseases［J］. Biomolecules, 2022, 12(12): 1811.

[47] [47] SHEN W, TEO K Y C, WOOD J P M, et al. Preclinical and clinical studies of photobiomodulation therapy for macular oedema［J］. Diabetologia, 2020, 63(9): 1900-1915.

[48] [48] AHMED S A, GHONEIM D F, MORSY M E, et al. Low-level laser therapy with 670 nm alleviates diabetic retinopathy in an experimental model［J］. Journal of Current Ophthalmology, 2021, 33(2): 143-151.

[49] [49] KARU T I. Mitochondrial signaling in mammalian cells activated by red and Near-IR radiation［J］. Photochemistry and Photobiology, 2008, 84(5): 1091-1099.

[50] [50] LIU Z, BUTOW R A. Mitochondrial retrograde signaling［J］. Annual Review of Genetics, 2006, 40: 159-85.

[51] [51] FREITAS L F, HAMBLIN M R. Proposed mechanisms of photobiomodulation or low-level light therapy［J］. IEEE Journal of Selected Topics in Quantum Electronics, 2016, 22(3): 1-17.

[52] [52] WALKER B R, MORAES C T. Nuclear-mitochondrial interactions ［J］. Biomolecules, 2022, 10, 12(3): 427.

[53] [53] KARU T I, PYATIBRAT L V, KOLYAKOV S F, et al. Absorption measurements of a cell monolayer relevant to phototherapy: reduction of cytochrome c oxidase under near IR radiation［J］. Journal of Photochemistry and Photobiology B-Biology, 2005, 81(2): 98-106.

[54] [54] HAMBLIN M R. Mechanisms and mitochondrial redox signaling in photobiomodulation［J］. Photochemistry and Photobiology, 2018, 94(2): 199-212.

[55] [55] HAMBLIN M R. Photobiomodulation or low-level laser therapy ［J］. Journal of Biophotonics, 2016, 9: 1122-1124.

[56] [56] BEIRNE K, ROZANOWSKA M, VOTRUBA M. Photostimulation of mitochondria as a treatment for retinal neurodegeneration［J］. Mitochondrion, 2017, 36: 85-95.

[57] [57] GOPALAKRISHNAN S, MEHRVAR S, MALEKI S, et al. Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa［J］. Scientific Reports, 2020, 10(1): 20382.

[58] [58] NIE F, HAO S, JI Y, et al. Biphasic dose response in the antiinflammation experiment of PBM［J］. Lasers in Medical Science, 2023, 38(1): 66.

[59] [59] HU X, ZHOU L, WANG H, et al. The value of photo biological regulation based on nano semiconductor laser technology in the treatment of hypertension fundus disease［J］. Journal of Nanoscience and Nanotechnology, 2021, 21(2):1323-1330.

[60] [60] LANDIS E G, PARK H N, CHRENEK M, et al. Ambient light regulates retinal dopamine signaling and myopia susceptibility［J］. Investigative Ophthalmology & Visual Science, 2021, 62(1): 28.

[61] [61] CHAKRABORTY R, LANDIS E G, MAZADE R, et al. Melanopsin modulates refractive development and myopia［J］. Experimental Eye Research, 2022, 214: 108866.

[62] [62] HUANG F, SHU Z, HUANG Q, et al. Retinal dopamine D2 receptors participate in the development of myopia in mice［J］. Investigative Ophthalmology & Visual Science, 2022, 63(1): 24.

[63] [63] SORBELLINI E, RUCCO M, RINALDI F. Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update［J］. Lasers in Medical Science, 2018, 33: 1431-1439.

[64] [64] TIAN Z, WANG P, HUANG K, et al. Photobiomodulation for Alzheimer’s disease: photoelectric coupling effect on attenuateing Aβ neurotoxicity［J］. Lasers in Medical Science, 2023, 38(1): 39.

[65] [65] GENEVA I I. Photobiomodulation for the treatment of retinal diseases: a review［J］. International Journal of Ophthalmology, 2016, 9(1): 145-152.

[66] [66] WEI Shuang, LI Yujun, ZHANG Fengmin. Study and application of red light-emitting diode (LED) in clinical diseases［J］. Acta Laser Biology Sinica, 2019, 28(5): 405-409.

[67] [67] ZHANG X, LI H, LI Q, et al. Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer［J］. World Journal of Surgical Oncology, 2018, 16(1): 222.

[68] [68] ZHANG C, SHI Y, WU L, et al. Far-red light triggered production of bispecific T cell engagers (BiTEs) from engineered cells for antitumor application［J］. ACS Synthetic Biology, 2022, 11(2): 888-899.

[69] [69] SHEN W, TEO K Y C, WOOD J P M, et al. Preclinical and clinical studies of photobiomodulation therapy for macular oedema［J］. Diabetologia, 2020, 63(9): 1900-1915.

[70] [70] MORIMURA Y, OKADA A A, HAYASHI A, et al. Histological effect and protein expression in subthreshold transpupillary thermotherapy in rabbit eyes［J］. Archives of Ophthalmolog, 2004, 122(10): 1510-1515.

[71] [71] Expert workgroup of expert consensus on repeated low-level redlight as an anternative treatment for children myopia (2022).

          Expert consensus on repeated low-level red-light as an alternative treatment for childhood myopia (2022)［J］. Chinese Journal of Experimental Ophthalmology, 2022, 40(7): 599-603.

[72] [72] Ministry of Industry and Information Technology. Safety of laser products―Part 1: Equipment classification and requirements: GB 7247.1—2012［S］. Beijing: Standards Press of China, 2012.

[73] [73] PAPAGEORGIOU E, ASPROUDIS I, MACONACHIE G, et al. The treatment of amblyopia: current practice and emerging trends ［J］. Graefe’s Archive for Clinical and Experimental Ophthalmology, 2019, 257(6): 1061-1078.

[74] [74] PINELES S L, AAKALU V K, HUTCHINSON A K, et al. Binocular treatment of amblyopia: a report by the American Academy of Ophthalmology［J］. Ophthalmology, 2020, 127(2): 261-272.